| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Association between provider recommendation and influenza vaccination status among children
|
Kahn, Katherine E.
|
|
2018
|
36 |
24 |
p. 3486-3497
|
article
|
| 2 |
BCG vaccine: WHO position paper, February 2018 – Recommendations
|
World Health Organization,
|
|
2018
|
36 |
24 |
p. 3408-3410
|
article
|
| 3 |
Challenges for the registration of vaccines in emerging countries: Differences in dossier requirements, application and evaluation processes
|
Dellepiane, Nora
|
|
2018
|
36 |
24 |
p. 3389-3396
|
article
|
| 4 |
Cholera vaccine: WHO position paper, August 2017 – Recommendations
|
World Health Organization,
|
|
2018
|
36 |
24 |
p. 3418-3420
|
article
|
| 5 |
Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines
|
Vannice, Kirsten S.
|
|
2018
|
36 |
24 |
p. 3411-3417
|
article
|
| 6 |
Composition of gut microbiota and its influence on the immunogenicity of oral rotavirus vaccines
|
Magwira, Cliff A.
|
|
2018
|
36 |
24 |
p. 3427-3433
|
article
|
| 7 |
Correlates of HPV vaccine initiation and provider recommendation among male adolescents, 2014 NIS-Teen
|
Landis, Kathryn
|
|
2018
|
36 |
24 |
p. 3498-3504
|
article
|
| 8 |
Decreased accumulation of subgenomic RNA in human cells infected with vaccine candidate DEN4Δ30 increases viral susceptibility to type I interferon
|
Bustos-Arriaga, José
|
|
2018
|
36 |
24 |
p. 3460-3467
|
article
|
| 9 |
Does consecutive influenza vaccination reduce protection against influenza: A systematic review and meta-analysis
|
Bartoszko, Jessica J.
|
|
2018
|
36 |
24 |
p. 3434-3444
|
article
|
| 10 |
Editorial Board/Aims and Scope
|
|
|
2018
|
36 |
24 |
p. IFC
|
article
|
| 11 |
Evaluating scenarios of locations and capacities for vaccine storage in Nigeria
|
Hirsh Bar Gai, Dor
|
|
2018
|
36 |
24 |
p. 3505-3512
|
article
|
| 12 |
Heterologous prime–boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus
|
Jung, Seo-Yeon
|
|
2018
|
36 |
24 |
p. 3468-3476
|
article
|
| 13 |
Immunogenicity of a Staphylococcus aureus-cholera toxin A2/B vaccine for bovine mastitis
|
Misra, N.
|
|
2018
|
36 |
24 |
p. 3513-3521
|
article
|
| 14 |
Influenza vaccine effectiveness in hospitalised Hong Kong children: Feasibility of estimates from routine surveillance data
|
Yeung, Karene Hoi Ting
|
|
2018
|
36 |
24 |
p. 3477-3485
|
article
|
| 15 |
Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal Zika virus infection in immunocompetent BALB/c mice
|
Wang, Ran
|
|
2018
|
36 |
24 |
p. 3522-3532
|
article
|
| 16 |
Optimization of human papillomavirus (HPV) type 16 E7-expressing lactobacillus-based vaccine for induction of mucosal E7-specific IFNγ-producing cells
|
Komatsu, Atsushi
|
|
2018
|
36 |
24 |
p. 3423-3426
|
article
|
| 17 |
Pharmacies versus doctors’ offices for adolescent vaccination
|
Shah, Parth D.
|
|
2018
|
36 |
24 |
p. 3453-3459
|
article
|
| 18 |
Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations – Latin America, 2013
|
El Omeiri, Nathalie
|
|
2018
|
36 |
24 |
p. 3555-3566
|
article
|
| 19 |
Selecting the right indicators to ensure optimised implementation of BCG vaccination policy
|
Thysen, Sanne Marie
|
|
2018
|
36 |
24 |
p. 3406-3407
|
article
|
| 20 |
Sub-optimal protection against past hepatitis B virus infection where subtype mismatch exists between vaccine and circulating viral genotype in northern Australia
|
Cheah, Benjamin C.
|
|
2018
|
36 |
24 |
p. 3533-3540
|
article
|
| 21 |
The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease
|
Lim, Heeji
|
|
2018
|
36 |
24 |
p. 3445-3452
|
article
|
| 22 |
Vaccination in immunocompromised host: Recommendations of Italian Primary Immunodeficiency Network Centers (IPINET)
|
Martire, Baldassarre
|
|
2018
|
36 |
24 |
p. 3541-3554
|
article
|
| 23 |
WHO/IVI global stakeholder consultation on group A Streptococcus vaccine development: Report from a meeting held on 12–13 December 2016
|
Osowicki, Joshua
|
|
2018
|
36 |
24 |
p. 3397-3405
|
article
|
| 24 |
WHO position paper, Meningococcal A conjugate vaccine: Updated guidance, February 2015
|
World Health Organization,
|
|
2018
|
36 |
24 |
p. 3421-3422
|
article
|
| 25 |
WHO Strategic Advisory Group of Experts (SAGE) on immunization: Request for nominations
|
|
|
2018
|
36 |
24 |
p. 3567
|
article
|
Journal description